EMV — EMvision Medical Devices Share Price
0.000.00%
Last trade - 00:00- AU$167.61m
- AU$156.75m
- AU$11.56m
- 15
- 20
- 73
- 30
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 10.88 | ||
| Price to Tang. Book | 11.34 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 19.43 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -30.01% | ||
| Return on Equity | -58.61% | ||
| Operating Margin | -62.08% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 0.98 | 0.52 | 4.38 | 7.09 | 11.56 | 6.54 | 9.99 | 59.06% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First-Generation device detect clinically significant changes, at the bedside, when time matters. Its Second-Generation device light weight device is embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location.
Directors
- John Keep NEC
- Ron Weinberger CEO
- Scott Kirkland EDR
- Emma Waldon SEC
- Philip Dubois NID (73)
- Tony Keane NID
- Geoff Pocock NID
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 11th, 2017
- Public Since
- December 13th, 2018
- No. of Shareholders
- 3,517
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 85,516,535
- Address
- Suite 4, 65 Epping Rd,, Macquarie Park, SYDNEY, 2113
- Web
- https://emvision.com.au/
- Phone
- +61 286675337
- Auditors
- BDO Audit Pty Ltd
Upcoming Events for EMV
Similar to EMV
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
Aroa Biosurgery
Australian Stock Exchange - SEATS
FAQ
What is the EMvision Medical Devices share price?
As of Today at 20:26 UTC, shares in EMvision Medical Devices are trading at AU$1.96. This share price information is delayed by 15 minutes.
How has the EMvision Medical Devices share price performed this year?
Shares in EMvision Medical Devices last closed at AU$1.96 and the price had moved by -8.84% over the past 365 days. In terms of relative price strength the EMvision Medical Devices share price has underperformed the ASX All Ordinaries Index by -12.14% over the past year.
What are the analyst and broker recommendations for EMvision Medical Devices?
The overall consensus recommendation for EMvision Medical Devices is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the EMvision Medical Devices dividend yield?
EMvision Medical Devices does not currently pay a dividend.
Does EMvision Medical Devices pay a dividend?
EMvision Medical Devices does not currently pay a dividend.
When does EMvision Medical Devices next pay dividends?
EMvision Medical Devices does not currently pay a dividend.
How do I buy EMvision Medical Devices shares?
To buy shares in EMvision Medical Devices you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of EMvision Medical Devices?
As of the previous close price of AU$1.96, shares in EMvision Medical Devices had a market capitalisation of AU$167.61m.
Where are EMvision Medical Devices shares listed?
Here are the trading details for EMvision Medical Devices:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: EMV
What kind of share is EMvision Medical Devices?
Based on an overall assessment of its quality, value and momentum EMvision Medical Devices is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a EMvision Medical Devices share price forecast for 2025?
The analyst consensus target price for shares in EMvision Medical Devices is AU$2.30. That is 17.35% above the last closing price of AU$1.96.
Analysts covering EMvision Medical Devices currently have a consensus Earnings Per Share (EPS) forecast of -AU$0.09 for the next financial year.
Find out moreWhat is the trend in the EMvision Medical Devices share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like EMvision Medical Devices. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +0.81%.
As of the last closing price of AU$1.96, shares in EMvision Medical Devices were trading +0.71% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the EMvision Medical Devices PE Ratio?
The EMvision Medical Devices PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$1.96.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of EMvision Medical Devices?
EMvision Medical Devices' management team is headed by:
- John Keep - NEC
- Ron Weinberger - CEO
- Scott Kirkland - EDR
- Emma Waldon - SEC
- Philip Dubois - NID
- Tony Keane - NID
- Geoff Pocock - NID